1. Home
  2. CASH vs VOR Comparison

CASH vs VOR Comparison

Compare CASH & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$78.48

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$22.35

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
VOR
Founded
1954
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CASH
VOR
Price
$78.48
$22.35
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$107.50
$45.33
AVG Volume (30 Days)
181.5K
697.7K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
0.23%
N/A
EPS Growth
N/A
N/A
EPS
6.29
N/A
Revenue
$839,894,000.00
N/A
Revenue This Year
$7.56
N/A
Revenue Next Year
$6.02
N/A
P/E Ratio
$12.58
N/A
Revenue Growth
11.29
N/A
52 Week Low
$65.93
$6.50
52 Week High
$101.26
$49.95

Technical Indicators

Market Signals
Indicator
CASH
VOR
Relative Strength Index (RSI) 32.06 47.59
Support Level $76.80 $21.90
Resistance Level $85.41 $24.44
Average True Range (ATR) 1.55 1.13
MACD -0.23 -0.19
Stochastic Oscillator 8.10 12.44

Price Performance

Historical Comparison
CASH
VOR

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: